Back to results
US 8,138,167 B2Granted
Methods for treating lung cancers
AssigneeOncotherapy Science, Inc.
InventorsYusuke Nakamura, Yataro Daigo
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeOncotherapy Science, Inc.
InventorsYusuke Nakamura, Yataro Daigo
Estimating the term…
The present invention provided methods for treating lung cancers using therapeutic agents for lung cancers comprising erbB receptor inhibitors as active ingredients. Methods for examining the responsiveness of lung cancer patients to erbB receptor inhibitors by using blood amphiregulin (AREG) as an indicator were provided. Furthermore, methods for treating lung cancers in which responsiveness to an erbB receptor inhibitor is determined based on blood AREG concentration, and in which therapeutic agents are selectively administered to patients expected to be responsive, were also provided. Advanced therapeutic effects can be expected by administering an erbB receptor inhibitor to patients predicted to be responsive. The present invention contributes to the improvement of therapeutic effects of gefitinib (Product name: Iressa®) and such on lung cancers.
A method for examining the responsiveness to a therapeutic agent for a lung cancer comprising an erbB receptor inhibitor as an active ingredient, wherein the method comprises the steps of:
Dependencies are inferred from the claim text.